These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18364583)

  • 21. Esophageal pH monitoring goes wireless.
    Lawrence BL; Taylor D
    Nursing; 2007 Oct; 37(10):26-7. PubMed ID: 17906527
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical importance of impedance measurements.
    Agrawal A; Castell DO
    J Clin Gastroenterol; 2008; 42(5):579-83. PubMed ID: 18364586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease.
    Emerenziani S; Ribolsi M; Sifrim D; Blondeau K; Cicala M
    Neurogastroenterol Motil; 2009 Mar; 21(3):253-8. PubMed ID: 19019016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attachment disorder: a decline in the performance of the Bravo pH system.
    Francis DL
    Am J Gastroenterol; 2008 Oct; 103(10):2663. PubMed ID: 18855870
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
    Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current indications of esophageal pH-monitoring].
    Armas Ramos H; Molina Arias M; Peña Quintana L; Eizaguirre Sexmilo I; Juste Ruiz M; Sánchez Ruiz F; Bousoño García C
    An Esp Pediatr; 2002 Jan; 56(1):49-56. PubMed ID: 11792245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How can we optimize the performances of 24-hour esophageal pH-monitoring for the diagnosis of gastroesophageal reflux disease?].
    Karoui S; Serghini M; Zouiten L; Boubaker J; Filali A
    Tunis Med; 2008 Oct; 86(10):861-4. PubMed ID: 19472802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid gastroesophageal reflux and intensity of symptoms in children with gastroesophageal reflux disease. Comparison of primary gastroesophageal reflux and gastroesophageal reflux secondary to food allergy.
    Semeniuk J; Kaczmarski M
    Adv Med Sci; 2008; 53(2):293-9. PubMed ID: 19095581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A pilot study on diagnosing laryngopharyngeal reflux disease by pH monitoring in laryngopharynx].
    Feng GJ; Zhang LH; Zhao LL; Liu YL
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):805-8. PubMed ID: 18756981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new pH catheter for laryngopharyngeal reflux: Normal values.
    Sun G; Muddana S; Slaughter JC; Casey S; Hill E; Farrokhi F; Garrett CG; Vaezi MF
    Laryngoscope; 2009 Aug; 119(8):1639-43. PubMed ID: 19504553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New technologies to evaluate esophageal function.
    Ravi K; Francis DL
    Expert Rev Med Devices; 2007 Nov; 4(6):829-37. PubMed ID: 18035949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and clinical utility of the Bravo pH capsule in children.
    Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
    J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to use: a pH study.
    Tighe MP; Cullen M; Beattie RM
    Arch Dis Child Educ Pract Ed; 2009 Feb; 94(1):18-23. PubMed ID: 19158334
    [No Abstract]   [Full Text] [Related]  

  • 35. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux.
    Loots CM; Benninga MA; Davidson GP; Omari TI
    J Pediatr; 2009 Feb; 154(2):248-52. PubMed ID: 18823910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the different characteristics of sensed reflux events among different heartburn groups.
    Schey R; Shapiro M; Navarro-Rodriguez T; Fass SS; Han B; Wendel C; Fass R
    J Clin Gastroenterol; 2009 Sep; 43(8):699-704. PubMed ID: 18797407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with physiological acid exposure and positive symptom association scores: a distinct group within the GORD spectrum.
    de Vries DR; van Herwaarden MA; Smout AJ; Samsom M
    Neurogastroenterol Motil; 2009 Aug; 21(8):820-e53. PubMed ID: 19239623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigations for esophageal motility and reflux].
    Wiesel PH; Maerten P; Guyot J
    Rev Med Suisse; 2009 Jan; 5(187):176-8, 180-4. PubMed ID: 19271428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wireless capsule pH monitoring: does it fulfil all expectations?
    Maerten P; Ortner M; Michetti P; Dorta G
    Digestion; 2007; 76(3-4):235-40. PubMed ID: 18174686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.